Cronos (CRON) Change in Receivables (2020 - 2026)
Cronos' (CRON) quarterly Change in Receivables came in at -$879000.0 in Q1 2026, down 125.78% year-on-year from $3.4 million in Q1 2025, and down 114.11% quarter-over-quarter from $6.2 million in Q4 2025.
Cronos (CRON) Change in Receivables (2020 - 2026) Analysis & Trends
Cronos' Change in Receivables history runs 7 years deep, the most recent figure standing at -$879000.0 for Q1 2026.
- On a quarterly basis, Change in Receivables fell 125.78% year-over-year to -$879000.0 in Q1 2026; TTM through Mar 2026 was $12.5 million, a 366.06% increase from a year earlier, with the FY2025 full-year figure at $16.7 million, up 1725.63% from the prior year.
- Change in Receivables eased to -$879000.0 in Q1 2026 per CRON's latest filing, from $6.2 million in the prior quarter.
- Across five years, Change in Receivables topped out at $6.4 million in Q2 2025 and bottomed at -$8.2 million in Q1 2023.
- The 5-year median for Change in Receivables is $1.1 million (2024), against an average of $604941.2.
- Across the five-year window, Change in Receivables slumped 332.32% in 2023 and surged 497.29% in 2025, its largest moves.
- Year by year, Change in Receivables stood at $3.9 million in 2022, then plunged by 157.43% to -$2.2 million in 2023, then plunged by 101.12% to -$4.5 million in 2024, then surged by 238.93% to $6.2 million in 2025, then sank by 114.11% to -$879000.0 in 2026.
- Per Business Quant, the three latest CRON Change in Receivables figures stand at -$879000.0 (Q1 2026), $6.2 million (Q4 2025), and $716000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | -879,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -879,000.00 |
| Mar 31, 2026 | -879,000.00 |
| Dec 31, 2025 | 6.23 Mn |
| Dec 31, 2025 | 6.23 Mn |
| Sep 30, 2025 | 716,000.00 |
| Sep 30, 2025 | 716,000.00 |
| Jun 30, 2025 | 6.39 Mn |
| Jun 30, 2025 | 6.39 Mn |
| Mar 31, 2025 | 3.41 Mn |
| Mar 31, 2025 | 3.41 Mn |
| Dec 31, 2024 | -4.49 Mn |
| Dec 31, 2024 | -4.49 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | -2.23 Mn |
| Dec 31, 2023 | -2.23 Mn |